Explore convalescent plasma treatment for COVID-19 in this 44-minute expert-led seminar presented by Professor David Roberts, Associate Medical Director of NHS Blood and Transplant. Delve into the evidence, program components, and operational challenges of implementing convalescent plasma therapy during the pandemic. Examine the Recovery study, scale of work, and strategies for reducing attrition. Discover remarkable stories, press coverage, and future work in this field. Gain insights into epidemiological aspects, trial design, recruitment processes, and potential side effects such as prothrombotic effects. Learn about antibody-mediated pathogenesis, plasma donation procedures, and current results. This comprehensive seminar, part of The Royal College of Pathologists' COVID-19 series, provides a thorough overview of convalescent plasma treatment, addressing key questions and offering valuable contact details for further information.
Convalescent Plasma for the Treatment of COVID-19 – Presented by Professor David Roberts
The Royal College of Pathologists via YouTube
Overview
Syllabus
Introduction
Evidence
Why not a major convalescent plasma program
What we have done in this epidemic
epidemiological aspects of the epidemic
components of the program
Recovery study
Scale of work
Operational problems
Reducing attrition
Remarkable stories
Press coverage
Headlines
Future work
Summary
Acknowledgements
Is anyone else doing this
How many patients have been enrolled
Can you reach a target in a given time
What was the basis of saying 28 days
Are you doing a throat swab
Are you doing a blood test
Trial design
Recruitment
Antibody mediated pathogenesis
Plasma donation
Prothrombotic effect
Results so far
Contact details
Conclusion
Taught by
The Royal College of Pathologists
